ASMLs, Balancing

ASML's Balancing Act: Washington's Questions Meet Amsterdam's Raised Ambitions

Published on 08/16/2026 at 18:21 | Redaktion boerse-global.de

ASML raises 2025 outlook to €43-45B sales, hits High-NA EUV production milestone with Intel, while facing US inquiry over alleged China exports.

ASML Faces US China Probe Amid Record Orders and High-NA EUV Milestone
ASML Holding Illustration mit AI erstellt übermittelt durch boerse-global.de

The Dutch lithography giant finds itself navigating two very different currents this week. On one side, a freshly upgraded annual forecast and a landmark production milestone for its next-generation technology. On the other, a US government inquiry into whether its most advanced machines have quietly found their way to China — a charge the company flatly denies.

ASML, the world's sole producer of EUV lithography systems, has confirmed it is aware of the probe, which centers on allegations that its equipment may have reached Chinese buyers through indirect channels, circumventing export controls in place since Donald Trump's first presidency. The company insists it has shipped no EUV systems to China, and the outcome of the review remains unresolved. The stakes are considerable: any substantiated finding would carry not just regulatory fallout but potential reputational damage with Washington and American chipmakers.

The investigation lands at a moment when the company's order book tells a decidedly more upbeat story. Management now targets full-year sales of €43 billion to €45 billion, up from previous guidance, with a gross margin between 54 and 56 percent. The third-quarter outlook calls for revenue of €11 billion to €12 billion and a margin of 55 to 57 percent. Those figures build on a second quarter that already beat internal expectations: net sales of €9.3 billion, net income of €2.9 billion, and earnings per share of €7.59, all against a 54.0 percent gross margin.

Demand visibility extends well beyond the current year. ASML plans to expand manufacturing capacity for low-NA EUV and DUV immersion systems by roughly 30 percent in 2027 compared with 2026, with a similar expansion under review for 2028. The investment appetite reflects a semiconductor industry increasingly powered by artificial intelligence spending, as CEO Christophe Fouquet has emphasized.

Should investors sell immediately? Or is it worth buying ASML Holding?

A crucial validation of that strategy arrived from a customer. Intel Foundry has moved part of its Core Ultra Series 3 processors — codenamed Panther Lake — into high-volume production using ASML's High-NA EUV technology on 18A manufacturing levels at its Oregon facility. The yields reportedly match those of the established NXE systems, offering ASML tangible proof that its multibillion-euro bet on the next lithography generation is paying off commercially. Intel and SK Hynix have embraced the technology, even as TSMC continues to view the systems as prohibitively expensive. Fouquet expects the first chips from the new machines to roll out within months.

Shareholders, meanwhile, are being rewarded for their patience. The company repurchased roughly €1.1 billion of its own stock during the second quarter under the 2026–2028 buyback program, and paid an interim dividend of €1.88 per share on August 5.

Institutional positioning, however, tells a more fragmented story. SEC filings for the second quarter reveal a sharp divide among fund managers. Steadview Capital Management established a new position of approximately 10,837 shares worth about $21.56 million, while Axon Capital increased its holding by nearly a quarter to 2,230 shares. Elsewhere, the mood was more cautious: TD Asset Management slashed its stake by 89 percent, New Paradigm Capital Management sold 1,000 shares to leave just 200, and both Principal Financial Group and Account Management trimmed their exposures. Institutions collectively own roughly 26 percent of ASML's shares.

Wall Street's consensus has yet to waver. The average price target sits at $1,970.33 with a "Moderate Buy" rating. JPMorgan and Bank of America see upside to $2,400 and $2,345 respectively, while RBC takes a more measured view at $2,000. Bernstein reaffirmed its buy recommendation on August 10.

The share price reflects the tension between operational momentum and geopolitical uncertainty. The stock closed Friday at €1,590.00, down 1.0 percent on the day, though still up 5.4 percent over seven trading sessions and 73 percent since the start of the year. That leaves the shares roughly 9 percent below the 52-week high of €1,748.00 reached in late June — a gap some market participants read as investor caution amid the unresolved China probe and mixed fund flows.

With a market capitalization near €606.72 billion, ASML remains one of Europe's most valuable technology companies. The next test comes October 14, when third-quarter results will show whether the raised guidance is holding up — and whether the company can keep its balance on the geopolitical tightrope.

Ad

ASML Holding Stock: New Analysis - 16 August

Fresh ASML Holding information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated ASML Holding analysis...

Disclaimer...

en | NL0010273215 | ASMLS | boerse | 69955931 |